Tae Hyun Kim

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Immune Response

Signaling Pathway

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hyejin Kim, Chaewon Park, Tae Hyun Kim
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 12 (9) (2023)
Hyejin Kim, Chaewon Park, Tae Hyun Kim
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 12 (9) (2023)
Hyejin Kim, Chaewon Park, Tae Hyun Kim
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease. Cells 12 (9) (2023)
Yoonji Ha, Inju Jeong, Tae Hyun Kim
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 10 (10) (2022)
Tae Hyun Kim, Dong-Gyun Hong, Yoon Mee Yang
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. Biomedicines 9 (12) (2021)
Tae Hyun Kim, Ja Hyun Koo, Sang Geon Kim, Chang Yeob Han, Yong-In Kim, Shi-Young Park, Il Je Cho, Chang Ho Lee, Cheol Soo Choi, Jung Weon Lee, Won Kim, Je-Yeol Cho, Sang Geon Kim
Overproduction of inter-α-trypsin inhibitor heavy chain 1 after loss of Gα13 in liver exacerbates systemic insulin resistance in mice. Science translational medicine 11 (513) (2020)